|
|
||||||||
Address correspondence to Jimmie P. Leleszi, DO, Department of Psychiatry/Psychology, Children's Hospital of Michigan, 3901 Beaubien, Detroit, MI 48201-2119.E-mail: jleleszi{at}med.wayne.edu
Pain management in end-of-life care presents a unique set of opportunities for patients and physicians. Physicians will encounter patients at the end of life regardless of type of specialty practice. Symptom relief is the concern of all physicians. Knowledge of "total pain" concepts along with basic end-of-life pain management offers much to patients and their families. Osteopathic principles and treatment philosophy complement quality pain management in end-of-life care. Physicians providing supportive care can assist patients and their families with comfort at the end of life. Good pain management at the end of life enhances the patient-physician relationship.
Even before end of life, nearly half of patients with cancer report moderate to severe pain; up to 30% report the pain as severe; and an estimated 25% will die in pain. Persons with other noncancer diagnoses also report significant pain.2 Dr Cicely Saunders, founder of modern hospice care, conceptualized pain associated with the dying process as "total pain."2
Total pain is the sum of four components: physical noxious stimuli, affect or emotional discomfort, interpersonal conflicts, and nonacceptance of one's own dying. (Figure 1). These four components may individually or in combination affect patients' perception of their total pain (Figure 2).3(p17) Lack of physicians' understanding of the influence of each of these four components may result in less-than-optimal pain management at the end of life.2
|
|
The "gold standard" of pain management is constant pain assessment. Pain is whatever the patient says it is. Simply asking patients about their pain is the best way to obtain this information.4(p301) Patients describe nonphysical components of pain as "discomfort." Byock5 wrote that in dying persons, pain is never purely physical. Things related to when and how they will eventually die influence their pain. These things include being abandoned; becoming undignified in terms of what they do, how they look, and how they smell; being a burden to their familiesnot only a physical strain, but also a financial hardship; and dying in pain alone.5 Any one of these concerns causes individuals to suffer and therefore must be addressed to provide good management of pain symptoms.
Physical pain is not universal with every death, but discomfort is usually present.
All physicians should be concerned with relief of symptoms, and relief is obviously the concern of all physicians, and they should focus on end-of-life care as part of comprehensive patient care. Pain therapy may become an issue for care at anytime in the dying process. Physicians must be able to address adequately the role of pain with end-of-life patient care. Knowledge of the principles of providing proper pain management at the end of life can enhance the physician-patient relationship.
| Total PainPhysical Pain |
|---|
|
|
|---|
Physical pain can be categorized in terms of its temporal nature (ie, acute or chronic) and delineated as to three types based on neurophysiologic mechanisms (ie, somatic, visceral, and neuropathic) (Figure 3). Regardless of mechanism, breakthrough and incident pain may occur.
|
Acute Pain
Acute pain results from nociceptor stimulation, usually is time-limited,
and often responds to analgesic medications or osteopathic manipulative
treatment. Pain perception is usually the result of an acute injury such as a
surgical intervention and can occur at end of
life.3(p17),4(p299)
Chronic Pain
Determination of chronic pain is based on duration of pain beyond 3 months
after an acute injury. Acute pain can be resolved, but chronic pain must be
managed and presents an entirely different challenge to both patient and
physician. The two goals of treating patients with such pain are reduction of
related symptoms and restoration of maximal function. Chronic pain is often
multifactorial, sources being as diverse and additive as that from migraine
headache, osteoarthritis, dental caries, diabetic neuropathy, and
cancerall of which may occur in the same patient. Delineating and
targeting treatment for each symptom allows for optimal symptom relief and
better global
functioning.4(p299)
Somatic Pain
Somatic pain results from stimulation of nociceptors in the skin and deep
musculoskeletal tissues. It is described as being a well-localized "deep
aching feeling" with tenderness to palpation. Common sources of somatic
pain are arthritic joints, osteopathic lesions, fractures, and
abscesses.3(p23)
Visceral Pain
Visceral pain occurs from stretching or activation of nociceptors in the
linings or serosa of organs. In contrast to somatic pain, visceral pain is
difficult to localize. Visceral pain is described as "deep
pressure," "cramping," "spasms," or
"squeezing." Nausea, diaphoresis, and emesis are frequently
present. Palpation over the site may elicit an accompanying somatic
pain.3(pp24,52)
Neuropathic Pain
Neuropathic pain results from damage to the peripheral nervous system or
the central nervous system (CNS), or both. It is described as
"sharp," "electric," or "burning" pain,
singly or in combination, and is usually found in the same distribution
pattern as a sensory peripheral nerve. Pain resulting from trauma to the CNS
that partially or completely separates the CNS from the peripheral nervous
system is termed deafferentation pain.
Central pain may be the result of a cerebral vascular accident and is characterized as "vicelike" or "throbbing," or both; headaches are described as "dull" and "never-relenting."3(pp21,24)
Breakthrough Pain and Incident Pain
Breakthrough pain is characterized as a temporary increase in pain from the
basal, acute, or chronic pain level. It is frequently described as worsening
pain at the latter part of the regularly scheduled analgesic-dose interval.
Incident pain can occur during diagnostic or therapeutic procedures, or it may
be caused by physiologic maneuvers such as valsalva when passing flatus.
Physicians should anticipate each of these types of pain and have the
appropriate comprehensive pain management in
place.3(p34)
Pain Scales
Pain scales are universally used for patients to convey the intensity of
their pain throughout treatment. Physicians should ask patients to describe
the nature of the pain as well the severity. Patients and healthcare
professionals concur in their perceptions when pain is of moderate intensity.
Pain of moderate to severe intensity is often accurately reported by patients
and undervalued by healthcare professionals. Using a particular pain scale is
not as important in the care of patients as the consistent use of the same
pain scale. Patients' perception of an acceptable pain level should be the
endpoint of the therapy. The endpoint of therapy should be the patient's
perception of an acceptable pain
level.6 Physicians
should always believe their
patients.3(p17)
| Total PainAnxiety |
|---|
|
|
|---|
Anxiety may be due to many organic causes (Figure 4) and may occur in the course of pain management if patients are not receiving the prescribed pain medication(s), or are given an inadequate amount or reduced frequency. Anxiety may also be caused by altered metabolic states such as coronary occlusion, hypocalcemia, hypoglycemia, hypoxia, delirium, occult bleeding, tumors (especially pheochromocytoma, thyroid, parathyroid, insulin- or ACTH-producing tumors), and sepsis. Relief of the organic-based symptoms caused by these conditions often ameliorates the patients' anxiety. Acute alcohol withdrawal, rapid tapering of corticosteroids, and side effects of bronchodilators can cause symptoms of anxiety. Metoclopramide use is frequently associated with negative emergent akathisia resulting in a patient's feeling anxious. Anxiety may also be preexisting and should be managed as any other comorbid medical condition.8(pp304-305),9(pp748-750)
|
Even when patients are adequately treated, the thought that pain relief will not be available at the end of life causes some to have great anxiety. Abandonment by their physicians, families, or friends, as well as fear of dying alone, is another source of symptomatic anxiety at the end of life.
Anxiety at the end of life is the reason to conduct research to evaluate novel treatment modalities. The US Food and Drug Administration is currently permitting a Phase II dose-response pilot study of +3,4-methylenedioxymethamphetamine (street drug Ecstasy). The study goal is to evaluate this medication's effectiveness in reducing anxiety and bringing about a sense of calm in patients with advanced cancer (http://www.maps.org/research/mdma/canceranxiety/protocolfda.pdf).
| Total PainInterpersonal Interactions |
|---|
|
|
|---|
| Total PainNonacceptance |
|---|
|
|
|---|
In the middle stage, most patients resolve their anger and denial. Depression is common in this stage as individuals are aware they will indeed die, but they do not view death as immediate. Supportive family and friends are helpful if the dying persons do not have negative interpersonal conflicts. Others in this intermediate stage have an intensified positive emotional resolve.
The third stage is defined by dying individuals' acceptance of the imminence of their death. Nonacceptance is evidenced by intense distress with the proximity of death and is a source for increased total pain. This model is helpful for physicians who may anticipate the need for support of patients at the end of life.
Spirituality is a function of personal values, not specific religious tenets. Hay10 provides a spiritual model that is compatible with medical constructs for good end-of-life care. There are four versions of individual spirituality according to Hay:
| Pain management in End-of-Life Care |
|---|
|
|
|---|
Opioids are often the medication of choice for end-of-life pain. They are safe and effective for the treatment of patients with moderate to severe pain, and they have side effects that can be managed effectively.3(p17)
Myths continue to limit the use of opioids. Physicians often avoid using opioids fearing the addiction of their patients. Addiction is known psychiatrically as substance abuse, a condition defined by the DSM IV-TR as a maladaptive pattern of substance use manifested by recurrent and significant adverse consequences related to the repeated use of the substance.7(p198) Patients' pre-opioid statenot merely exposure to opioidsdetermines their potential for opioid abuse. Active substance abusers requiring end-of-life pain management challenge the most tolerant of medical care systems. Analgesic therapy must be given until death. Physical dependence must also be medically managed during dying.8(pp372-373)
Patients and their families may delay the use of opioids fearing their use foretells imminent death, and patients may fear that opioid use early in their care will diminish the effectiveness of such medication. It is the responsibility of physicians to counsel patients that this result will not be allowed to occur. Dose adjustment, appropriate monitoring, and management of adverse reactions must continue for all patients.3(pp25-33)
Nausea, sedation, and pruritus, are common temporary side effects of opioids10(pp81-86) and usually resolve in 3 to 5 days.1 Antihistamines such as diphenhydramine and hydroxyzine are effective for treating patients for nausea and pruritus.11(pp81-86) The elderly may experience confusion, hallucinations, and cognitive impairment with opioid use. A different opioid at a lower dose may help; however, advancing disease may be the cause of confusion in the elderly.3(p32)
Constipation is the most frequent side effect with sustained opioid therapy and should be anticipated and prevented. Constipation may cause bowel obstruction. The liberal use of laxatives, hydration, and exercise facilitate bowel function with ongoing opioid therapy.3(pp35-39) Herrmann12 suggests that osteopathic manipulative treatment has a definite role in the prevention and treatment of postoperative adynamic ileus. Intermittent pressure applied to the lower thoracic and lumbar spine with the patient in the supine position for approximately 2 minutes every 2 hours is effective.
Opioid overdose is rare. Signs of opioid toxicity include myoclonus and respiratory depression. Physicians should consider opioid toxicity when patients' level of consciousness declines and respirations are fewer than 6 per minute. These conditions may also represent disease progression or active dying. Other physical signs of opioid toxicity are myoclonic twitching, constricted pupils, and skeletal muscle flaccidity with cold or clammy skin.3(pp25-27,40)
| Total PainOsteopathic Medical Care |
|---|
|
|
|---|
|
Harmony among these components results in good health.13 Patients at end of life are not in a state of harmony and hence not in a state of good health. The body is not unified for continued life; self-regulatory mechanisms are unable to rectify the end-of-life process; and functioning is disruptive, causing a change in mechanical structure. Rational therapy would be to return the body to a unit in which structure and function are reciprocally interrelated.
End-of-life care is the rational therapy that allows for reduction of pain symptoms and facilitation of as much function as possible. Application of the four components of osteopathic philosophy is consistent with management of total pain at the end of life.
The use of osteopathic manipulative medicine can relieve some acute and chronic physical pain. Osteopathic techniques used in postoperative patients have application at the end of life. Gentle direct or indirectly administered myofascial release techniques have been used for treatment of chronic pain. High velocity techniques are usually not used.13-16 The physician's touch demonstrates patient acceptance and relieves fear of isolation and abandonment.4(p301) Osteopathic physicians should incorporate osteopathic principles into their management of total pain in patients at the end of life.
| Comment |
|---|
|
|
|---|
Figure 6 provides some helpful resources for end-of-life care.
|
| Footnotes |
|---|
This continuing medical education publication supported by an unrestricted educational grant from Purdue Pharma LP
From the Department of Psychiatry & Behavioral Sciences, Wayne State University School of Medicine (Dr Leleszi), and Children's Hospital of Michigan (Drs Leleszi and Lewandowski), in Detroit; Bon Secours Cottage Health Services in Grosse Pointe, Mich (Drs Leleszi and Lewandowski); and Hospices of Henry Ford Health (Dr Lewandowski) in Detroit, Mich.
| References |
|---|
|
|
|---|
2. Saunders CM. The challenge of terminal care. In: Symington T, Carter RL, eds. Scientific Foundations of Oncology. London, England: Heinemann; 1976:673 -679.
3. Storey P, Knight CF. UNIPAC Three: Assessment and Treatment of Pain in the Terminally III. 2nd ed. American Academy of Hospice and Palliative Medicine. New York, NY: Mary Ann Lieber, Inc Publishers; 2003:17,21 ,23-40,52,
4. Doyle D, Hanks GWC, Cherny N, Calman K. Oxford Textbook of Palliative Medicine. 3rd ed. New York, NY: Oxford University Press; 2000:299,301 .
5. Byock I. Dying Well: Peace and Possibilities at the End of Life. New York, NY: Riverhead Books;1997 .
6. Grossman SA, Sheidler VR, Swedeen K, Mucenski J. Piantadosi S. Correlation of patient and caregiver ratings of cancer pain. J Pain Symptom Manage. 1991;6(2):53 -57.[Medline]
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text Revision. Washington, DC: American Psychiatric Association;2000 :198,820 .
8. Holland JC, Rowland JH. Handbook of Psychooncology: Psychological Care of the Patient With Cancer. New York, NY: Oxford University Press; 1989:304 -305.
9. Doyle D, Hanks GWC, Cherny N, McDonald N. Oxford Textbook of Palliative Medicine. 2nd ed. New York, NY: Oxford University Press; 1998:144 -146,748-750.
10. Hay MW. Principles in building spiritual assessment tools. Am J Hospice Palliat Care.1989; 6(5):25 -31.
11. Levetown M, Frager G. In: Storey P, Knight CF, eds. UNIPAC Eight: The Hospice/Palliative Medicine Approach to Caring for Pediatric Patients. American Academy of Hospice and Palliative Medicine. New York, NY: Mary Ann Lieber, Inc Publishers; 2003:81 -86.
12. Herrmann EP. Postoperative adynamic ileus: its prevention and treatment by osteopathic manipulation. The DO. October1965; 163-164 .
13. Seffinger MA, King HH, Ward RC, Jones JM, Rogers FJ, Patterson MM. Osteopathic philosophy. In: Ward RC, executive ed. Foundations for Osteopathic Medicine. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2003:3 -18.
14. Nicholas AS, Oleski SL. Osteopathic manipulative treatment for
postoperative pain. J Am Osteopath Assoc.2002; 102(Suppl 3):S5
-S8.
15. Andersson GB, Lucente T, Davis AM, Kappler RE, Lipton, JA, Leurgans
S. A comparison of osteopathic spinal manipulation with standard care for
patients with low back pain. N Engl J Med.1999; 341:1426
-1431.
16. Bigos S, Bowyer O, Braen G, Brown K, Deyo R, Haldemna S, et al. Acute Low back Problems in Adults. Clinical Practice Guideline 14. Rockville, Md: AHCPR Publication No. 95-0642. Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services; December 1994.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |